Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Black River Asset Management was a global alternative asset management firm providing hedge fund and private equity solutions to institutional investors. It was originally an independently managed subsidiary of Cargill, with core competencies in fixed income, equity relative value, commodity and emerging markets trading and investing. In 2015–2016, the company underwent a major restructuring due to declining investor demand for certain funds. This resulted in the closure of several hedge funds and ultimately the split of Black River into three separate firms focused on different investment strategies—fixed income (Garda Capital Partners), private equity (Proterra Investment Partners), and emerging market credit (Argentem Creek Partners). The original entity is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Black River Asset Management.